ALFA Filings
Every announcement, straight from the exchange
Every Symbiotec Pharmalab other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Symbiotec Pharmalab Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31 of the SEBI LODR Regulations.
Symbiotec Pharmalab has filed the routine quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ending September 30, 2026.
Designated persons of Symbiotec Pharmalab sold equity shares worth ₹11.94 crore in the open market. This disclosure complies with PIT Regulation 7(2).
Symbiotec Pharmalab Ltd has disclosed the list of Key Managerial Personnel authorized to determine materiality of events as required under Regulation 30(5) of SEBI regulations.